Status:
ACTIVE_NOT_RECRUITING
Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Rush University
National Opinion Research Center
Conditions:
Frailty
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.
Detailed Description
Physical activity is essential for all age groups, across all comorbidities and geriatric syndromes; it has been described as the 'ideal' intervention for aging. Increasing physical activity among hom...
Eligibility Criteria
Inclusion
- age greater than or equal to 60 years
- has at least 2 chronic conditions
- requires any assistance to leave the home (this may include requiring someone to drive, requiring the use of a cane or walker, or similar)
- can read 14 point font from a 2-foot distance on a tablet-sized screen
- can hear spoken voice from 2-foot distance
- SPPB score of less than or equal to 9 but greater than 3 on a 12-point scale to target moderate but not severe functional impairment.
Exclusion
- reported history of moderate to advanced cognitive impairment;
- inability to stand unassisted;
- inability to understand English (because the intervention is currently only available in English);
- life expectancy less than 12 months or enrolled in Hospice;
- a medical condition making unsupervised physical activity potentially unsafe including: stroke within prior 12 months, acute myocardial infarction or unstable angina in the prior 6 months, uncontrolled arrhythmias, dissecting aortic aneurysm, acute endo/pericarditis, acute thromboembolism, acute or severe heart or respiratory failure, uncontrolled hypertension greater than 180/100, fracture or joint replacement within the prior 3 months, infections affecting one's general health condition, severe peripheral vascular disease.
- severe functional impairment as indicated by an SPPB score less than 3 (out of 12);
- baseline Montreal Cognitive Assessment of less than or equal to 18/30;
- inability to understand consent (teach back).
Key Trial Info
Start Date :
October 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2026
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT05337514
Start Date
October 26 2022
End Date
June 30 2026
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637